When BC molecular subtypes were considered, the significant association between DKC1 protein and poor patient outcome was observed in the ER+ high proliferation (i.e. luminal B), HER2+ and TNBC classes whereas the high mRNA expression was only limited to the luminal B subtype. Here, DKC1 is linked to breast cancer.